Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-10-000038

Chairman/CEO/President bought 15,000 shares at an average $0.26 ($3,900)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · Chairman/CEO/President

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2010-09-07 Purchase : show line 1 in the form +10,000 $0.25 $2,500 2,413,021 I
2010-09-07 Purchase : show line 2 in the form +5,000 $0.28 $1,400 2,418,021 I
Open-market purchases · 15,000 sh · avg $0.26 · $3,900
Loading xslF345X03/primary_doc.xml…